Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells - PubMed (original) (raw)
Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells
H K Yi et al. Eur J Cancer. 2001 Nov.
Abstract
Insulin-like growth factor (IGF)-I and -II are potent mitogens and postulated to exert autocrine, and paracrine effects on growth regulation in human gastric cancer. Their mitogenic effects are tightly regulated by the IGF binding proteins (IGFBPs). In this study, we evaluated the mRNA expression of IGF-I, IGF-II and the IGFBPs in a panel of human gastric cancer cell lines, and normal and tumour tissue specimens from patients with gastric cancer by reverse transcriptase-polymerase chain reaction (RT-PCR) and competitive PCR. Conditioned media (CM) of the gastric cancer cell lines were studied for the secretion of the IGFBPs by western ligand blot (WLB) and western immunoblot (WIB). IGF-I and IGF-II were expressed in all of the gastric cancer cell lines, and the normal and tumour tissue specimens. Overexpression of the IGFs, in particular, IGF-II, was observed in the tumour tissues. The expression pattern of IGFBPs was heterogeneous among the gastric cancer cell lines. IGFBP-2 was expressed in all of the gastric cancer cell lines, whereas IGFBP-1 was not detected in any cell lines. IGFBP-4 was expressed in the most of cell lines. IGFBP-3, IGFBP-5 and IGFBP-6 were expressed in approximately 50% of cell lines. In addition, exogenous IGF-I and IGF-II stimulated the proliferation of gastric cancer cells, suggesting the existence of a functional IGF system in gastric cancer. Taken together, our data-suggest that the IGF-IGFBP system may play an important role in the initiation, progression and metastasis of gastric cancer. Further studies are needed to understand the exact role of IGFs and IGFBPs in gastric neoplasia.
Similar articles
- Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells.
Kimura G, Kasuya J, Giannini S, Honda Y, Mohan S, Kawachi M, Akimoto M, Fujita-Yamaguchi Y. Kimura G, et al. Int J Urol. 1996 Jan;3(1):39-46. doi: 10.1111/j.1442-2042.1996.tb00628.x. Int J Urol. 1996. PMID: 8646598 - Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K, Wegmann BR, Havemann K, Jaques G. Noll K, et al. J Clin Endocrinol Metab. 1996 Jul;81(7):2653-62. doi: 10.1210/jcem.81.7.8675593. J Clin Endocrinol Metab. 1996. PMID: 8675593 - Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK, Kim SY, Hwang PH, Kim CY, Yang DH, Oh Y, Lee DY. Yi HK, et al. Biochem Biophys Res Commun. 2005 May 13;330(3):760-7. doi: 10.1016/j.bbrc.2005.03.045. Biochem Biophys Res Commun. 2005. PMID: 15809062
Cited by
- Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.
Lim EJ, Hong DY, Park JH, Joung YH, Darvin P, Kim SY, Na YM, Hwang TS, Ye SK, Moon ES, Cho BW, Do Park K, Lee HK, Park T, Yang YM. Lim EJ, et al. PLoS One. 2012;7(4):e33361. doi: 10.1371/journal.pone.0033361. Epub 2012 Apr 2. PLoS One. 2012. PMID: 22485142 Free PMC article. - Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population.
Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH, Zhao J, Cai L, Rao JY, Heber D, Zhang ZF. Mu LN, et al. Int J Cancer. 2005 Oct 10;116(6):972-83. doi: 10.1002/ijc.21137. Int J Cancer. 2005. PMID: 15856451 Free PMC article. - Targeted therapies in gastric cancer treatment: where we are and where we are going.
Tomasello G, Ghidini M, Liguigli W, Ratti M, Toppo L, Passalacqua R. Tomasello G, et al. Invest New Drugs. 2016 Jun;34(3):378-93. doi: 10.1007/s10637-016-0330-2. Epub 2016 Feb 12. Invest New Drugs. 2016. PMID: 26873643 Review. - Diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study.
Yang HJ, Kang D, Chang Y, Ahn J, Ryu S, Cho J, Guallar E, Sohn CI. Yang HJ, et al. Gastric Cancer. 2020 May;23(3):382-390. doi: 10.1007/s10120-019-01033-8. Epub 2019 Dec 18. Gastric Cancer. 2020. PMID: 31853749 - Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer.
Liu Q, Jiang J, Zhang X, Zhang M, Fu Y. Liu Q, et al. Front Oncol. 2021 Oct 21;11:723131. doi: 10.3389/fonc.2021.723131. eCollection 2021. Front Oncol. 2021. PMID: 34745945 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous